Marathon Pharmaceuticals Report issue

Contributed to NME For profit Phase 1 Phase 3
Founded: Northbrook IL United States (2008)
Status: Acquired by PTC Therapeutics (2017)

Organization Overview

First Clinical Trial
2014
NCT02286635
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2015

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Alternative names

Marathon Pharmaceuticals, LLC